Longeviti Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 44

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

Longeviti General Information

Description

Operator of a neurotechnology company intended to innovate manufacturing and globally distribute functional neurosurgical implants for complex brain surgeries. The company's products provide space within the brain or skull to fit lifesaving neurotechnologies, including valves, brain-computer interfaces, drains, intracranial pressure diagnostics, and blood-brain barrier (BBB) drug-delivery capabilities, enabling healthcare practitioners and patients to retrieve lifesaving neuro information in seconds and in real time, versus traditional imaging and diagnostic methods.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 101 West Dickman Street
  • Suite 600
  • Baltimore, MD 21230
  • United States
+1 (410)
Primary Industry
Surgical Devices
Other Industries
Diagnostic Equipment
Therapeutic Devices
Corporate Office
  • 101 West Dickman Street
  • Suite 600
  • Baltimore, MD 21230
  • United States
+1 (410)

Longeviti Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Longeviti Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 23-Sep-2026 Completed Generating Revenue
10. Secondary Transaction - Private 01-Mar-2026 Completed Generating Revenue
9. Later Stage VC 07-Aug-2025 Completed Generating Revenue
8. Later Stage VC (Series BB) 05-Feb-2025 Completed Generating Revenue
7. Later Stage VC 28-Dec-2023 Completed Generating Revenue
6. Accelerator/Incubator 16-Nov-2023 Completed Generating Revenue
5. Later Stage VC 19-Apr-2023 Completed Generating Revenue
4. Later Stage VC 19-Jan-2022 Completed Generating Revenue
3. Later Stage VC (Series C) 23-Sep-2020 $6M $17.6M Completed Generating Revenue
2. Early Stage VC (Series B) 28-Jun-2019 $9.6M $11.6M Completed Generating Revenue
To view Longeviti’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Longeviti Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a neurotechnology company intended to innovate manufacturing and globally distribute functional neurosurgica
Surgical Devices
Baltimore, MD
44 As of 2025

Lyon, France
 

Salt Lake City, UT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Longeviti Competitors (4)

One of Longeviti’s 4 competitors is Carthera, a Venture Capital-Backed company based in Lyon, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Carthera Venture Capital-Backed Lyon, France
Blackrock Neurotech Venture Capital-Backed Salt Lake City, UT
Paradromics Venture Capital-Backed Austin, TX
Neuralink Venture Capital-Backed Fremont, CA
To view Longeviti’s complete competitors history, request access »

Longeviti Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Longeviti Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Soleus Capital Asset Manager Minority
Ecphora Capital Venture Capital Minority
NeuroTech Harbor Accelerator/Incubator
Abell Foundation Not-For-Profit Venture Capital Minority
TEDCO Venture Capital Minority
To view Longeviti’s complete investors history, request access »

Longeviti FAQs

  • When was Longeviti founded?

    Longeviti was founded in 2016.

  • Where is Longeviti headquartered?

    Longeviti is headquartered in Baltimore, MD.

  • What is the size of Longeviti?

    Longeviti has 44 total employees.

  • What industry is Longeviti in?

    Longeviti’s primary industry is Surgical Devices.

  • Is Longeviti a private or public company?

    Longeviti is a Private company.

  • What is Longeviti’s current revenue?

    The current revenue for Longeviti is .

  • How much funding has Longeviti raised over time?

    Longeviti has raised $38.8M.

  • Who are Longeviti’s investors?

    Soleus Capital, Ecphora Capital, NeuroTech Harbor, Abell Foundation, and TEDCO have invested in Longeviti.

  • Who are Longeviti’s competitors?

    Carthera, Blackrock Neurotech, Paradromics, and Neuralink are competitors of Longeviti.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process